DUBLIN–(BUSINESS WIRE)–The “Malaria Treatment Market Forecast to 2027 – COVID-19 Impact and Global Analysis By Treatment Type; Route of Administration; End User and Geography” report has been added to ResearchAndMarkets.com’s offering.
According to this report the global malaria treatment market was valued at US$ 1,508.12 million in 2019 and is projected to reach US$ 2,126.42 million by 2027; it is expected to grow at a CAGR of 4.4% from 2020 to 2027. The report highlights the key factors driving the market growth and prominent players with their developments in the market.
Based on treatment type, the malaria treatment market is segmented into vaccine, diagnostic test, and antimalarial agents. The diagnostic test segment held the largest share of the market in 2019. The growth of this segment is ascribed to the demand for high-quality and cost-efficient diagnostic methods, and introduction of novel diagnostic techniques. Also, the governments in the Middle East and Africa are taking measures to help the patients, such as Sanofi’s digitization steps to control malaria through MOSKI kit awareness in children in malaria endemic countries are being successful in the malaria treatment market.
The growth of the malaria treatment market is attributed to the high prevalence of malaria in low-income countries, and increasing initiatives undertaken by governments globally. However, increasing resistance to antimalarial drugs hinders the growth of this market.
Reasons to Buy
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the malaria treatment market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the global malaria treatment market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Market Dynamics
Drivers
- High Prevalence of Malaria in Low-Income Countries
- Increasing Initiatives Undertaken by Governments Globally
Restraints
- Increasing Resistance to Antimalarial Drugs
Opportunities
- Increasing Research for New Drugs and Vaccines
Future Trends
- Rapid Diagnostic Tests for Malaria
Companies Mentioned
- Advanz Pharmaceutical
- Ipca Laboratories Ltd
- Zydus Cadila
- Glenmark
- Olympus Corporation
- Abbott
- Sun Pharmaceutical Industries Ltd
- Sanofi
- GlaxoSmithKline plc
- Novartis AG
- TEVA PHARMACEUTICAL INDUSTRIES LTD
For more information about this report visit https://www.researchandmarkets.com/r/sd8kjz
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900